Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans
about
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systemsA FKBP5 mutation is associated with Paget's disease of bone and enhances osteoclastogenesis.Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.Fluoxetine Decreases the Proliferation and Adipogenic Differentiation of Human Adipose-Derived Stem Cells.Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational ImplicationsPurine and pyrimidine metabolism: Convergent evidence on chronic antidepressant treatment response in mice and humans.Treatment-resistant depression: are animal models of depression fit for purpose?The role of DNA methylation in the pathophysiology and treatment of bipolar disorder.FK506 binding protein 51 integrates pathways of adaptation: FKBP51 shapes the reactivity to environmental change.FKBP51 inhibits GSK3β and augments the effects of distinct psychotropic medications.The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51.Fluoxetine-enhanced autophagy ameliorates early brain injury via inhibition of NLRP3 inflammasome activation following subrachnoid hemorrhage in rats.Molecular network of neuronal autophagy in the pathophysiology and treatment of depression.FKBP5/FKBP51 enhances autophagy to synergize with antidepressant action.Rosiglitazone Exerts an Anti-depressive Effect in Unpredictable Chronic Mild-Stress-Induced Depressive Mice by Maintaining Essential Neuron Autophagy and Inhibiting Excessive Astrocytic ApoptosisTrazodone regulates neurotrophic/growth factors, mitogen-activated protein kinases and lactate release in human primary astrocytes.Hsp90-binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity.Salvianolic acid B protects against lipopolysaccharide-induced behavioral deficits and neuroinflammatory response: involvement of autophagy and NLRP3 inflammasome.Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function.The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease.Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.NLRP3 inflammasome: common nexus between depression and cardiovascular diseases.Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine.Psychological status in depressive patients correlates with metabolic gene expression.Beware of your Cre-Ation: lacZ expression impairs neuronal integrity and hippocampus-dependent memory.Hsp90 and FKBP51: complex regulators of psychiatric diseases.Emerging Treatment Approaches for Parkinson's Disease
P2860
Q22676705-C989772D-6CF5-47F0-881A-C9515336D626Q33635613-6071CD89-61AD-4261-93C3-0C7B84E9C47CQ33754082-BE9010CD-721C-4B39-89F1-748942249CD7Q34557613-D645D7CF-9AE7-4B9C-B3A1-40C4D958E0BEQ35902690-EFA9EFA1-E4D2-4F94-9E3E-6FC3F56E3796Q36366772-05F89A52-676A-4684-8067-5B0FAA4298BCQ37330439-A6918FEE-852C-4B2B-9F5B-1D14065CB188Q38569708-1673F6B9-8A0C-408A-B837-DC7EA61AA24DQ38872287-5B5865C5-5C8B-4220-B706-986C20FAF447Q38885066-B75AE9CD-5A15-4CFF-8FD9-0F293CA0B03BQ38890067-F5657D75-9797-44B2-A73E-3A68FADDB8B2Q39768470-08E795E6-2C56-4610-9668-637B8424ACB7Q41108330-71A81599-7236-4C84-B34D-D42B408A01DBQ41465471-DA051252-C7A8-4757-8A62-2AE9FC91775BQ41608479-3F578F56-4DC5-4CF3-826D-EB9641B0C9CDQ41673202-4E11E5FC-11BF-498C-89BF-12F5E7C5067CQ41850897-19F0B9D5-0B34-43B3-9B30-5471D400FD4DQ41882137-2562A3AD-591E-4966-9E6E-D49A84912002Q47144450-9D2D1D56-A9FF-4A85-8A9C-38401B9890F3Q47160893-8DBF836C-65BD-49E0-8B8C-F315CAFFA93CQ47329852-8200ADF5-2409-4D8A-A334-5EB019A1AFDDQ47826150-1E1CA6E9-AA0E-4946-9CCE-ABEC3491BB31Q48000075-36C9D5E2-1EEB-4377-A1D5-AA14BC9828B3Q48069881-52962417-A6AE-4964-8C35-83EF069C562BQ48114348-98184B85-5C50-4565-A808-B05E262BFE54Q50229323-93937D74-7CDA-45C7-A894-130B4E3D6143Q52420582-A5967250-071C-4D2E-8DFE-93C9659308B8Q57817579-257C202A-2024-464B-9082-3C25F5EC6F1F
P2860
Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Association of FKBP51 with pri ...... nce in cells, mice, and humans
@ast
Association of FKBP51 with pri ...... nce in cells, mice, and humans
@en
Association of FKBP51 with pri ...... nce in cells, mice, and humans
@nl
type
label
Association of FKBP51 with pri ...... nce in cells, mice, and humans
@ast
Association of FKBP51 with pri ...... nce in cells, mice, and humans
@en
Association of FKBP51 with pri ...... nce in cells, mice, and humans
@nl
prefLabel
Association of FKBP51 with pri ...... nce in cells, mice, and humans
@ast
Association of FKBP51 with pri ...... nce in cells, mice, and humans
@en
Association of FKBP51 with pri ...... nce in cells, mice, and humans
@nl
P2093
P2860
P50
P3181
P1433
P1476
Association of FKBP51 with pri ...... nce in cells, mice, and humans
@en
P2093
Andreas Zellner
Jens Stepan
Jürgen Zschocke
Kathrin Hafner
Klaus V Wagner
Lorenz Kollmannsberger
Nils C Gassen
Nina Dedic
Susanne Lucae
Thomas Kirmeier
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1001755
P407
P50
P577
2014-11-01T00:00:00Z